Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NephroGenex Inc (NASDAQ:NRX)

4.08
Delayed Data
As of Sep 02
 +0.11 / +2.77%
Today’s Change
3.40
Today|||52-Week Range
17.98
-69.44%
Year-to-Date
No recent news for NephroGenex Inc.

Today’s Trading

Previous close3.97
Today’s open4.08
Day’s range4.00 - 4.20
Volume16,230
Average volume (3 months)64,590
Market cap$41.6M
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)+89.09%
Earnings growth (this year)+0.93%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.82

Competitors

 Today’s
change
Today’s
% change
DITAMCON Distributing C...+0.10+0.12%
CBAYCymaBay Therapeutics...-0.07-2.60%
MCPIMed Cannabis Pharma ...+0.01+5.00%
BIOSBioScrip Inc+0.07+2.94%
Data as of 11:43am ET, 09/02/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$0.00
Annual profit (last year)-$16.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Pierre Legault
President &
Chief Scientific Officer
J. Wesley Fox Ahmann
Corporate headquarters
Durham, North Carolina

Forecasts

Partner Offers